More articles from 5.1 Airway Pharmacology and Treatment

Neurokinin-1 receptor antagonism for the treatment of cough in lung cancer
Amelie Harle, Fiona Blackhall, Alex Molassiotis, Kim Holt, Rachel Dockry, Philip Russell, Katy Burns, Ryan Robinson, Mark Birrell, Maria Belvisi, Jaclyn Smith

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5060; DOI: 10.1183/13993003.congress-2016.PA5060
Effect of high, medium, and low molecular weight hyaluronan on inflammation and oxidative stress in an in vitro model of human nasal epithelial cells
Giusy D. Albano, Anna Bonanno, Luca Cavalieri, Eleonora Ingrassia, Caterina Di Sano, Liboria Siena, Loredana Riccobono, Rosalia Gagliardo, Mirella Profita

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5064; DOI: 10.1183/13993003.congress-2016.PA5064
RPL554, an inhaled PDE3/4 inhibitor, causes comparable bronchodilation to high dose nebulised salbutamol in asthmatics with fewer systemic effects
Leif Bjermer, Johnston Stewart, Katharine Abbott-Banner, Kenneth Newman

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4905; DOI: 10.1183/13993003.congress-2016.PA4905
Anti-inflammatory activity of the bradykinin B₁R antagonist in a model of LPS-induced lung inflammation in cynomolgus monkey
Thierry Bouyssou, Birgit Jung, Peter Nickolaus, Jeff Duan, Feihong Dai, Henri Doods

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5063; DOI: 10.1183/13993003.congress-2016.PA5063
TRPM3: A regulator of airway sensory nerves and respiratory reflexes
Sara Bonvini, Maham Arshad, Michael A. Wortley, John J. Adcock, Eric Dubuis, Kassandra Kosmidou, Sarah A. Maher, Fisnik Shala, Joris Vriens, Thomas Voets, Mark A. Birrell, Maria G. Belvisi

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5070; DOI: 10.1183/13993003.congress-2016.PA5070
Maintenance of IRF1 by MAPK inhibition: A mechanism by which DUSP1 reduces glucocorticoid inhibition of CXCL10
Suharsh Shah, Mahmoud Mostafa, Mohammed Altonsy, Robert Newton

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5068; DOI: 10.1183/13993003.congress-2016.PA5068
Pharmacological characterization of the mechanism of action leading to synergism between glycopyrronium bromide and indacaterol fumarate
Luigino Calzetta, Paola Rogliani, Ermanno Puxeddu, Josuel Ora, Francesco Facciolo, Maria Gabriella Matera, Mario Cazzola

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5057; DOI: 10.1183/13993003.congress-2016.PA5057
Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease
Krupesh Patel, Chrishan Samuel, Simon Royce

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4891; DOI: 10.1183/13993003.congress-2016.PA4891
Adrenal insufficiency in asthma patients – Who is at risk?
Sam Roberts, Tim Sutherland, Jane Slough, Rhodri King, Robert Murray, Ian Clifton

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4899; DOI: 10.1183/13993003.congress-2016.PA4899
Neutrophils in bronchial mucosa, sputum and blood after administration of the CXCR2-antagonist AZD5069 - An explorative study in neutrophilic asthma
Henrik Watz, Anne Kirsten, Frauke Pedersen, Torsten Goldmann, Florian Stellmacher, Mohib Uddin, Bengt Larsson, Gerhard Böttcher, Anna Malmgren, Marteen Kraan, Klaus Rabe

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4892; DOI: 10.1183/13993003.congress-2016.PA4892

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages